News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
76 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (168)
2 (76)
4 (3)
5 (150)
6 (144)
7 (139)
8 (146)
9 (72)
10 (4)
11 (1)
12 (157)
13 (167)
14 (125)
15 (111)
16 (54)
17 (4)
19 (20)
20 (49)
21 (57)
22 (62)
23 (38)
25 (1)
26 (79)
27 (106)
28 (97)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
25
26
27
28
Policy
AstraZeneca Drops Phase III Asthma Drug as Company Posts Disappointing 2017 Financials
Failing numbers are putting a strain on CEO Pascal Soriot’s pledge of achieving $45B of annual revenue by 2023.
February 2, 2018
·
2 min read
·
Alex Keown
Policy
Array BioPharma Slaps $192M Lawsuit on AstraZeneca Over Cancer Drug Royalties
AstraZeneca did not immediately respond to a request for comment.
February 2, 2018
·
1 min read
Business
AbbVie Plans to Hire After Doubling Cambridge R&D Facility
With the additional space, AbbVie will hire 15 new employees.
February 2, 2018
·
2 min read
·
Alex Keown
Deals
Motus GI Preps for $30M IPO
The company plans to raise $30 million by offering 4.3 million shares at a price range of $6 to $8.
February 2, 2018
·
1 min read
Business
Amgen to Build New $300M Facility After Tax Changes
Amgen is expected to add 220 jobs to the local economy and employ up to 300 full-time employees.
February 2, 2018
·
2 min read
·
Mark Terry
Policy
FDA Slaps a Class I Recall on Vyaire’s Airlife Humidification Chambers
The manufacturing error could cause the chamber to split and allow water into the patient’s breathing circuit.
February 2, 2018
·
1 min read
Policy
Confirmed: Boston Scientific’s Lotus Valve is Off the Market Until 2019
The company’s CEO confirmed the news yesterday.
February 2, 2018
·
1 min read
Business
Arcturus CEO Ousted, Effective Immediately
Shares of Arcturusare down more than 8 percent in morning trading after the company announced it abruptly terminated Joseph E. Payne as president and CEO.
February 2, 2018
·
2 min read
·
Alex Keown
Deals
NCPC GeneTech Acquires China Rights to Anemia Drug From Korean Firm
NCPC GeneTech, the biotech division of North China Pharma, in-licensed China rights for a biosimilar to a second-gen renal anemia treatment from South Korea’s CJ Healthcare.
February 2, 2018
·
1 min read
Deals
M&A Chatter Swirls Over Amgen’s $70B Cashpile
Amgen reported its fourth-quarter financials yesterday, but in anticipation of this year’s hot merger-and-acquisition market, a lot of focus has been on the company’s considerable available cash.
February 2, 2018
·
2 min read
·
Mark Terry
1 of 8
Next
